| Device | Flow Rate | FiO₂ Delivered | Best For | ⚠️ Limitations |
|---|---|---|---|---|
| Nasal Cannula (NC) | 1–6 L/min | 24–44% | Mild hypoxemia. Stable patients. Most common starting point. | ⚠️ Uncomfortable > 6L (dries mucosa). Unreliable FiO₂ -depends on patient's minute ventilation and mouth breathing. |
| Simple Face Mask | 5–10 L/min | 35–55% | Moderate hypoxemia. Short-term use (ED, post-op). | ⚠️ Must run ≥ 5 L/min to prevent CO₂ rebreathing. Claustrophobic. Can't eat/talk well. |
| Venturi Mask | 4–12 L/min | Precise: 24%, 28%, 31%, 35%, 40%, 50% | COPD patients -need precise low FiO₂ (24–28%) to avoid suppressing hypoxic drive. Color-coded adapters. | ⚠️ Max 50% FiO₂. Bulky. Used mainly for COPD. |
| Non-Rebreather (NRB) | 10–15 L/min | 60–90% | Severe hypoxemia. Pre-oxygenation before intubation. CO poisoning. Trauma. | ⚠️ Reservoir bag must stay inflated. Not truly 100% -room air mixes around mask. If patient needs NRB → consider escalation. |
| High-Flow Nasal Cannula (HFNC) | 20–60 L/min | 21–100% (titratable) | Hypoxemic respiratory failure, post-extubation, immunocompromised (avoid intubation), pre-oxygenation. Delivers heated humidified O₂. | ⚠️ Generates ~1 cmH₂O PEEP per 10 L/min (so 60L ≈ 6 cmH₂O). Patient must breathe spontaneously. If still desatting on HFNC 60L/100% → intubate. |
| CPAP | BiPAP | |
|---|---|---|
| What it does | Single continuous pressure (like PEEP) | Two pressures: IPAP (inhale) + EPAP (exhale) |
| Helps with | Oxygenation only -splints airways open, recruits alveoli | Both oxygenation AND ventilation -IPAP augments tidal volume (blows off CO₂), EPAP = PEEP |
| Best for | Cardiogenic pulmonary edema, OSA | COPD exacerbation (hypercapnic failure), obesity hypoventilation, neuromuscular weakness |
| Typical settings | CPAP 5–10 cmH₂O | IPAP 10–20 / EPAP 5–8 cmH₂O. Start IPAP 10, EPAP 5. Titrate IPAP up by 2 q15–30 min for CO₂. |
| Pressure support | None (single pressure) | PS = IPAP − EPAP. Higher PS = more ventilatory support. PS of 10 cmH₂O is moderate support. |
| Setting | What It Controls | How to Titrate | Think of It As |
|---|---|---|---|
| EPAP | Oxygenation (splints alveoli open, recruits collapsed lung) | Start 5 cmH₂O. ↑ by 2 if SpO₂ < 90% despite FiO₂. Max ~10-12. | = PEEP. Treats the O₂ problem. |
| IPAP | Ventilation (how much air is pushed in per breath) | Start 10 cmH₂O. ↑ by 2 q15-30 min if CO₂ still high. Max ~20-25. | = Tidal volume driver. Treats the CO₂ problem. |
| PS (= IPAP − EPAP) | Tidal volume per breath | Higher PS → bigger breaths → more CO₂ blown off. Target PS 5-15 cmH₂O for most patients. | PS is essentially your tidal volume knob. PS of 10 ≈ TV of ~400-500 mL in most adults. |
| FiO₂ | Oxygen concentration | Start 100%, wean to target SpO₂ 88-92% (COPD) or 92-96%. Always wean FiO₂ before weaning pressures. | Supplemental O₂. Independent of IPAP/EPAP. |
| Rate (backup) | Minimum breaths/min if patient doesn't trigger | Set 12-16. Usually not needed, patient triggers their own breaths. | Safety net for apnea. |
| Problem | Which Knob to Turn | What to Do |
|---|---|---|
| SpO₂ low (oxygenation failure) | ↑ EPAP (or ↑ FiO₂) | EPAP recruits alveoli and improves V/Q matching. Think of it like adding PEEP on a vent. |
| CO₂ high (ventilation failure) | ↑ IPAP (keeping EPAP the same) | This increases PS, which increases tidal volume, which blows off more CO₂. ↑ IPAP by 2 cmH₂O every 15-30 min until pH improves. |
| Both | ↑ EPAP for O₂, ↑ IPAP for CO₂ | Always increase IPAP at least as much as EPAP to maintain the PS gap. If you raise EPAP by 2, raise IPAP by 2 also. |
Presentation: Brought in by EMS, severe respiratory distress, accessory muscle use, speaking in 1-2 word sentences. RR 32, SpO₂ 84% on 6L NC, HR 115, BP 155/90.
ABG on arrival: pH 7.22, PaCO₂ 78, PaO₂ 52, HCO₃ 30 (acute-on-chronic hypercapnic respiratory failure).
| Scenario | Starting IPAP / EPAP | PS | Goal | Titration Target |
|---|---|---|---|---|
| COPD exacerbation | 10-12 / 5 | 5-7 | ↓ CO₂, ↑ pH | ↑ IPAP q15-30 min → max 20-25. Target pH > 7.30. |
| Cardiogenic pulmonary edema | 10-12 / 8-10 | 2-4 | ↑ O₂, ↓ preload | Higher EPAP for recruitment. CPAP 10-12 is often enough. |
| Obesity hypoventilation | 14-18 / 8-10 | 6-10 | ↓ CO₂ | Need higher pressures due to chest wall compliance. ↑ IPAP aggressively. |
| Neuromuscular weakness | 10-14 / 5 | 5-9 | Augment weak inspiratory muscles | ↑ IPAP if NIF declining. Low threshold for intubation (GBS, MG crisis). |
| Post-extubation (prophylactic) | 8-10 / 5 | 3-5 | Prevent reintubation | Low support. Alternate with HFNC. Wean over 24-48h. |
| DNI / comfort care | 10-15 / 5-8 | 5-7 | Symptom relief | Titrate to comfort + dyspnea relief. No ABG targets. |
| Challenge | Why It Happens | What to Do |
|---|---|---|
| Higher IPAP needed | Chest wall is stiff → needs more pressure to generate the same tidal volume | Start IPAP 14-18 (not 10). May need IPAP 20-25 in BMI > 50. Don't be afraid to go higher. |
| Higher EPAP needed | Abdominal mass compresses diaphragm → atelectasis → V/Q mismatch → hypoxemia | Start EPAP 8-10 (not 5). Acts like higher PEEP to recruit collapsed bases. |
| Positioning matters hugely | Supine = diaphragm splinted by abdomen. Functional residual capacity drops. | Sit patient upright at 30-45° or reverse Trendelenburg. This alone can improve oxygenation dramatically. |
| Chronic CO₂ retention | Obesity hypoventilation syndrome (OHS), chronic hypercapnia with elevated bicarb | Don't normalize CO₂. Target their baseline PaCO₂ (often 50-60). Check HCO₃, if elevated, it's chronic. Over-ventilating → alkalosis → arrhythmias. |
| Mask leak | Facial fat makes mask seal harder | Use a full-face mask (oronasal). May need a larger size. Check for beard. Tighten straps but avoid skin breakdown. |
| Drug | MOA | Dose | Onset | Duration | Best For | ⚠️ Avoid If |
|---|---|---|---|---|---|---|
| INDUCTION AGENTS | ||||||
| Etomidate | GABA-A agonist | 0.3 mg/kg IV push | 15–30 sec | 5–15 min | Hemodynamically unstable -most neutral on BP. Most common RSI induction agent. | ⚠️ Adrenal suppression (single dose is clinically insignificant). Avoid in septic shock? -debated. |
| Ketamine (Ketalar) | NMDA antagonist | 1–2 mg/kg IV push | 30–60 sec | 10–20 min | Asthma/bronchospasm (bronchodilator), hypotension (preserves BP via sympathetic stimulation), elevated ICP (old teaching said avoid -now considered safe). | ⚠️ Psychosis/schizophrenia (emergence reactions). Increases secretions -give glycopyrrolate. |
| Propofol (Diprivan) | GABA-A agonist | 1.5–2.5 mg/kg IV push | 15–30 sec | 5–10 min | Status epilepticus (anticonvulsant), elevated ICP (lowers ICP). | ⚠️ Causes significant hypotension -avoid in shock, hypovolemia. Egg/soy allergy (controversial). |
| Midazolam (Versed) | GABA-A agonist (benzo) | 0.1–0.3 mg/kg IV push | 1–2 min | 15–30 min | Rarely used for RSI (slower onset). Backup option. Provides amnesia. | ⚠️ Hypotension. Slower onset than etomidate/ketamine. Can reverse with flumazenil. |
| PARALYTICS (NEUROMUSCULAR BLOCKERS) | ||||||
| Succinylcholine (Anectine) | Depolarizing NMB -mimics ACh, sustained depolarization → paralysis | 1–1.5 mg/kg IV push | 30–45 sec | 6–10 min | Fastest onset + shortest duration. Good when you need to quickly reassess neuro status (e.g., stroke). | ⚠️ Hyperkalemia (burns > 48h, crush injury, denervation, renal failure with K⁺ > 5.5). Malignant hyperthermia (personal/family history). Myasthenia gravis. |
| Rocuronium (Zemuron) | Non-depolarizing NMB -competitive ACh blocker at nicotinic receptor | 1.2 mg/kg IV push (RSI dose) | 45–60 sec | 45–70 min | When succinylcholine is contraindicated. Reversible with sugammadex (16 mg/kg for immediate reversal). Becoming first-line at many centers. | ⚠️ Long duration -if can't intubate AND can't ventilate, patient is paralyzed for 45+ min (unless sugammadex available). |
| Mode | How It Works | You Set | What Varies | Best For | ⚠️ Watch For |
|---|---|---|---|---|---|
| AC/VC Assist Control / Volume Control | Every breath (patient-triggered or machine-triggered) delivers a set tidal volume. | TV, RR, FiO₂, PEEP, flow rate | Pressure (Ppeak varies with compliance/resistance) | Most common mode. Default for most intubations. ARDS (guarantees 6 mL/kg TV). | ⚠️ If compliance drops → pressures rise → barotrauma. Watch Pplat. |
| AC/PC Assist Control / Pressure Control | Every breath delivers a set pressure for a set inspiratory time. | Pressure, I-time, RR, FiO₂, PEEP | Tidal volume (varies with compliance) | When you want to limit pressures strictly. Neonatal/pediatric. Some ARDS protocols. | ⚠️ If compliance worsens → TV drops → hypoventilation. Must monitor TV closely. |
| SIMV Synchronized Intermittent Mandatory Ventilation | Delivers set number of mandatory breaths. Patient can take extra breaths on their own (unsupported or with PS). | TV, RR, FiO₂, PEEP, PS level | Patient's spontaneous breaths are variable | Weaning mode -gradually reduce mandatory rate as patient takes over. | ⚠️ Increases work of breathing if PS too low on spontaneous breaths. Largely fallen out of favor -SBT preferred for weaning. |
| PSV Pressure Support Ventilation | Patient triggers every breath. Vent augments each breath with set pressure support. | PS level, FiO₂, PEEP | TV and RR (entirely patient-driven) | SBT (PS 5–8 cmH₂O), weaning assessment, awake cooperative patients. | ⚠️ No backup rate -if patient becomes apneic, no breaths are delivered. Need apnea backup alarm. |
| APRV Airway Pressure Release Ventilation | Sustained high pressure (P-high) with brief releases to low pressure (P-low) for CO₂ clearance. Essentially inverse-ratio CPAP. | P-high, T-high, P-low, T-low | TV during releases | Refractory ARDS -keeps alveoli open with sustained high pressure. Allows spontaneous breathing. | ⚠️ Complex to manage. Requires experience. Not proven superior to standard lung-protective ventilation. Hemodynamic effects from sustained high intrathoracic pressure. |
| Scenario | Mode | Why |
|---|---|---|
| Fresh intubation (default) | AC/VC | Guarantees tidal volume. Simple. Predictable. |
| ARDS | AC/VC (6 mL/kg PBW) | Must control TV tightly for lung protection. |
| COPD / asthma | AC/VC (low rate, long I:E) | Need guaranteed TV with long expiratory time to avoid air trapping. |
| High peak pressures | Switch AC/VC → AC/PC | Limits pressure delivery. But monitor TV -may drop. |
| Ready to wean / SBT | PSV 5–8 / PEEP 5 | Minimal support. Tests if patient can breathe independently. |
| Refractory ARDS | APRV (by experienced team) | Last resort before ECMO. Keeps alveoli recruited. |
| 🔵 Oxygenation (O₂) | 🔴 Ventilation (CO₂) | |
|---|---|---|
| What is it? | Getting oxygen INTO the blood | Getting CO₂ OUT of the blood |
| Measured by | PaO₂ (ABG) or SpO₂ (pulse ox) | PaCO₂ (ABG) or EtCO₂ (capnography) |
| Normal values | PaO₂ 80–100 mmHg, SpO₂ 94–98% | PaCO₂ 35–45 mmHg |
| Problem | Hypoxemia -O₂ too low | Hypercapnia -CO₂ too high Hypocapnia -CO₂ too low |
| Vent settings that fix it | FiO₂ (↑ = more O₂ delivered) PEEP (↑ = recruits collapsed alveoli, improves gas exchange surface area) | Respiratory Rate (↑ RR = blow off more CO₂) Tidal Volume (↑ TV = each breath removes more CO₂) Together = Minute Ventilation (MV = RR × TV) |
| Think of it as | How much oxygen you're putting IN the lungs | How much air you're moving THROUGH the lungs |
| ABG Shows | Problem | Adjust | ⚠️ Watch For |
|---|---|---|---|
| PaO₂ 55, SpO₂ 88% | Hypoxemia | ↑ FiO₂ and/or ↑ PEEP | FiO₂ > 0.6 for > 24h → O₂ toxicity. Wean FiO₂ first, then PEEP. |
| PaCO₂ 65, pH 7.22 | Respiratory acidosis (hypoventilating) | ↑ RR or ↑ TV (↑ minute ventilation) | Auto-PEEP in COPD. Pplat > 30 if TV too high. Max RR ~35 before ineffective. |
| PaCO₂ 25, pH 7.55 | Respiratory alkalosis (overventilating) | ↓ RR or ↓ TV (↓ minute ventilation) | Patient may be anxious/in pain → treat the cause. Don't just sedate to fix CO₂. |
| PaO₂ 55 AND PaCO₂ 60 | Both hypoxemic + hypercapnic | ↑ FiO₂/PEEP (for O₂) AND ↑ RR/TV (for CO₂). If refractory → prone + iNO + ECMO. | Suggests severe disease (ARDS + dead space). Consider prone, paralytics, iNO, ECMO. |
| PaO₂ 120, FiO₂ 1.0 | Over-oxygenating | ↓ FiO₂ (wean to target SpO₂ 92–96%) | Hyperoxia harms: ↑ mortality in cardiac arrest, stroke, MI. Wean FiO₂ aggressively. |
| PaO₂ (mmHg) | SpO₂ (%) | What it means |
|---|---|---|
| 40 | 70 | Mixed venous blood. Severe hypoxemia if arterial. |
| 50 | 80 | Critically low. On the steepest part of the cliff. |
| 60 | 90 | The "knee." Above this you're on the safe plateau; below, on a cliff. |
| ~95-100 | 97-100 | Normal arterial. Far up the plateau. |
| Direction | Effect | Caused by |
|---|---|---|
| RIGHT shift | Hgb releases O₂ more easily (higher P50). Good for tissues, bad for lungs at low PaO₂. | CADET, face Right: ↑ CO₂, Acidosis, 2,3-DPG (BPG), Exercise, Temperature. |
| LEFT shift | Hgb holds O₂ tighter (lower P50). Hgb saturates well in the lungs but unloads poorly to tissues. | Hypothermia, alkalosis, ↓ CO₂, ↓ 2,3-BPG (stored blood), CO poisoning, methemoglobin, fetal hemoglobin. |
| Type | Name | Mechanism | ABG Pattern | Common Causes | Treatment Focus |
|---|---|---|---|---|---|
| Type 1 | Hypoxemic | Failure of gas exchange -O₂ can't cross alveolar membrane into blood. V/Q mismatch, shunt, diffusion impairment. | PaO₂ < 60 PaCO₂ normal or low | Pneumonia, ARDS, pulmonary edema, PE, pulmonary fibrosis, atelectasis | 🔵 FiO₂ + PEEP → prone → iNO → ECMO |
| Type 2 | Hypercapnic | Failure of ventilation -can't move enough air to clear CO₂. Pump failure (muscles, drive, mechanics). | PaCO₂ > 50 pH < 7.35 PaO₂ may be low too | COPD, asthma, obesity hypoventilation, neuromuscular disease (GBS, MG, ALS), drug overdose (opioids), chest wall deformity | 🔴 RR × TV (↑ minute ventilation). BiPAP first if possible. |
| Type 3 | Perioperative | Atelectasis from anesthesia, supine positioning, diaphragm splinting (pain, abdominal distension). | PaO₂ low PaCO₂ usually normal | Post-surgical (especially abdominal/thoracic), obesity, poor pain control limiting deep breathing | Incentive spirometry, early mobilization, pain control, CPAP if needed |
| Type 4 | Shock | Hypoperfusion → insufficient O₂ delivery to tissues despite adequate lung function. Respiratory muscles fatigue from hypoperfusion. | Lactic acidosis Mixed picture | Cardiogenic shock, septic shock, hypovolemic shock, Category E PE | Treat the shock first (fluids, vasopressors, inotropes). Intubate to reduce O₂ consumption by respiratory muscles. |
| Parameter | Standard | ARDS | COPD/Obstructive |
|---|---|---|---|
| Mode | AC/VC or AC/PC | AC/VC | AC/VC or SIMV |
| Tidal Volume | 8 mL/kg PBW | 6 mL/kg PBW | 6–8 mL/kg PBW |
| Rate | 14–16 /min | 18–22 /min | 10–14 /min (avoid stacking) |
| FiO₂ | Start 1.0, wean | Wean to keep SpO₂ 88–95% | Target SpO₂ 88–92% |
| PEEP | 5 cmH₂O | 8–16 (ARDSnet table) | Auto-PEEP concern -keep low |
| I:E Ratio | 1:2 | 1:2 to 1:3 | 1:3 to 1:4 (more time to exhale) |
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Propofol (Diprivan) | 5–50 mcg/kg/min | IV | First-line sedation. ⚠️ Propofol infusion syndrome (PRIS) risk if > 48h or > 80 mcg/kg/min (check CK, triglycerides, lactate). |
| Fentanyl (Sublimaze) | 25–200 mcg/hr | IV | Analgesia-first approach. Preferred analgesic in ICU. Lipophilic -accumulates > 72h. |
| Cisatracurium | 1–3 mcg/kg/min | IV | Neuromuscular blockade for severe ARDS × 48h. Must have adequate sedation first -paralyzed + aware = torture. ACURASYS, 2010 |
| Dexmedetomidine | 0.2–1.5 mcg/kg/hr | IV | Less delirium than benzos MENDS, 2007. SEDCOM, 2009. DEXCOM, 2016: reduced delirium and shorter time to extubation vs midazolam. ⚠️ Bradycardia, hypotension. No respiratory depression -can use during SBT. |
| Indication | Why it works |
|---|---|
| Restore voice / phonation | Exhaled air is forced through the larynx instead of out the trach, giving audible speech. The primary reason it is placed and the biggest quality-of-life and delirium-reducing win. |
| Improve swallowing, reduce aspiration | Closing on exhalation restores subglottic pressure and normal aerodigestive pressures, improving laryngeal sensation, cough strength, and airway protection. |
| Better secretion clearance & cough | Restored subglottic pressure produces a more effective, productive cough so secretions clear through the mouth rather than needing trach suction. |
| Restore smell & taste | Re-establishing nasal and oral airflow returns olfaction, and with it taste and appetite. |
| Facilitate weaning & decannulation | Reintroduces upper-airway airflow and reconditions a more physiologic breathing pattern, a step toward capping and tube removal. |
| Restore physiologic PEEP | The closed exhalation phase recreates the native end-expiratory pressure that is lost when the upper airway is bypassed. |
| Type | Contraindication | Why |
|---|---|---|
| ABSOLUTE | Inflated cuff | Blocks the only exhalation route → air stacking → barotrauma / fatal arrest. Must be fully deflated first. |
| ABSOLUTE | Foam-filled cuff (e.g., Bivona Fome-Cuf) | Self-inflates and cannot be reliably kept deflated, so the exhalation path can re-occlude. Same trapping risk. |
| ABSOLUTE | Total laryngectomy | No patent connection from trachea to upper airway -exhaled air has nowhere to go. |
| ABSOLUTE | Unconscious / comatose / unstable | Cannot protect the airway or signal distress, so the valve cannot be safely trialed. |
| CAUTION | Severe upper-airway obstruction (tracheal/subglottic stenosis, bilateral vocal-fold paralysis, large granulation, or trach tube too big for the airway) | Not enough room to exhale around the tube. Always do the leak check first; no leak means do not place. |
| CAUTION | Severe aspiration risk | Redirecting airflow does not fix a grossly unsafe swallow; assess before trialing. |
| CAUTION | Thick, copious, unmanageable secretions | Secretions can occlude the valve membrane. |
| CAUTION | Severely reduced lung elasticity (end-stage obstructive disease) | Exhaling through the upper airway adds work of breathing the patient may not tolerate. |
Presentation: 45M admitted with severe bilateral pneumonia and hypoxemic respiratory failure. SpO₂ 82% on 15L NRB, intubated emergently. ABG post-intubation: pH 7.34, PaO₂ 70 on FiO₂ 0.8 → P/F ratio 88 (severe ARDS, <100).
Vent Strategy (ARDSNet): Mode AC/VC. PBW ~63 kg → TV 6 mL/kg PBW = 378 mL (set 380 mL). RR 18, PEEP 12, FiO₂ 0.8. Confirm Pplat after first breath: target <30 cmH₂O. Driving pressure (Pplat − PEEP) target <15 cmH₂O. ARMA, 2000
Escalation: P/F ratio persists <150 after 12–16h on optimized settings → initiate prone positioning for 16h/day. Consider neuromuscular blockade (Cisatracurium (Nimbex)) if severe patient-ventilator dyssynchrony. Repeat ABG 30 min after every vent change.
Teaching point: Always use PBW (predicted body weight, from height and sex), not actual body weight, for TV calculation. Over-ventilating causes ventilator-induced lung injury (VILI) and increases mortality, even a few extra mL/kg matters.
Presentation: 68F with severe AECOPD, on BiPAP for 4h with worsening hypercapnia (pH 7.18, pCO₂ 92). BiPAP failure → intubated with RSI using Ketamine (Ketalar) + Succinylcholine (Anectine).
Vent Strategy: Mode AC/VC. TV 6–8 mL/kg PBW. RR 12–14/min (low rate = more time to exhale). High inspiratory flow rate (60–80 L/min) to shorten inspiratory time. Target I:E ratio 1:4 (vs. normal 1:2) to maximize expiratory time and prevent breath stacking. Start PEEP 5.
Auto-PEEP check: Perform end-expiratory hold maneuver, press hold, read auto-PEEP off the ventilator display. Auto-PEEP >5 cmH₂O = air trapping. Treatment: decrease RR, increase expiratory time, aggressive bronchodilators (Albuterol + Ipratropium); if critical, briefly disconnect ETT and allow full passive exhalation.
Permissive hypercapnia: Target pH 7.25–7.35, not a normal pCO₂. Do not raise RR to normalize CO₂, this worsens air trapping. Hemodynamic stability is the goal, not a normal ABG.
Presentation: 55M intubated day 5 for Category E PE with hemodynamic instability, now improving. On AC/VC, RR 14, TV 450 mL, PEEP 5, FiO₂ 0.35. SpO₂ 96%, hemodynamically stable, off vasopressors. RASS −1, follows commands, intact cough.
Step 1, SAT (Sedation Vacation): Hold Propofol and Fentanyl infusions every morning. Assess within 30 min: opens eyes to voice, follows commands, breathing comfortably? Fail criteria: agitation, RR >35, SpO₂ <88%, hemodynamic instability → restart sedation at half dose. Girard, 2008
Step 2, SBT (Spontaneous Breathing Trial): SAT passes → switch to PS 5 / PEEP 5 for 30–120 min. Readiness: FiO₂ ≤40%, PEEP ≤8, hemodynamically stable. Pass criteria: RR <35, SpO₂ >90%, no significant accessory muscle use, RSBI (f/VT in L) <105. Example: RR 18, TV 0.45L → RSBI = 40 → pass.
Decision: Passes both SAT + SBT → proceed to extubation. Fails repeatedly (≥3 attempts over multiple days) → discuss tracheostomy to facilitate long-term weaning, reduce dead space, and improve patient comfort.
| Parameter | Frequency | Target / Action |
|---|---|---|
| ABG | 30 min after any vent change, then q4–6h | pH, PaCO2, PaO2, P/F ratio. Guides FiO2/PEEP (oxygenation) and RR/TV (ventilation) adjustments. |
| Daily SBT assessment | Every morning | Assess readiness: FiO2 ≤ 40%, PEEP ≤ 8, hemodynamically stable, no high-dose vasopressors, adequate mental status. RSBI < 105 (RR/TV in liters) predicts successful extubation. Girard, 2008: paired SAT + SBT improves outcomes. |
| Plateau pressure | q4–6h or with vent changes | Pplat < 30 cmH2O (lung protective). If exceeding → reduce TV, check for pneumothorax, bronchospasm, or mucus plugging. |
| Driving pressure | q4–6h | Driving pressure < 15 cmH2O (Pplat - PEEP). Strongest predictor of ARDS mortality Amato, 2015. Optimize by adjusting TV and PEEP. |
| SpO2 / FiO2 trending | Continuous SpO2, track P/F ratio | SpO2 target 88–95% in ARDS, 94–98% otherwise. Worsening P/F may indicate disease progression, fluid overload, or new complication. |
| Auto-PEEP check | q shift and with clinical concern | Expiratory hold maneuver. Auto-PEEP > 5 = air trapping → increase expiratory time (decrease RR, decrease I:E ratio). Common in COPD/asthma. |
| Sedation level (RASS) | q4h | Target RASS -2 to 0 (light sedation). Deeper sedation only if specific indication (prone, paralysis, severe agitation). Daily sedation awakening trial (SAT). |
| Daily SAT + SBT | Every morning | Girard, 2008: paired protocol -SAT first (hold sedation, assess arousal) → if passes → SBT (PS 5–8/PEEP 5 for 30–120 min). Reduces vent days and mortality. |
| VAE surveillance | Daily | Ventilator-associated events: new/worsening infiltrate, rising FiO2/PEEP after period of stability, fever, purulent secretions. Prevent with: HOB 30-45°, oral care, DVT/PUD prophylaxis, daily SBT. |